BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC on December 17, 2024.
The company intends to use the net proceeds from the offering to purchase gold bullion and for general corporate purposes.
Offering Details
Shares of common stock (or pre-funded warrants) are being offered by the Company.
Use of Proceeds
The net proceeds will be used to purchase gold bullion and for working capital.
Joint Book-Running Managers
Clear Street and Needham & Company are acting as joint managers of the offering.
- BioSig Technologies aims to raise capital through this offering to support its investment policy and working capital needs.
- The successful completion of the offering is crucial for the company's strategic financial plans.
The public offering by BioSig Technologies Inc. represents a significant move towards strengthening its financial position and pursuing its investment policy.